Pharmaceutical Executive
Ambien CR, the sleep medication that "helps you fall asleep fast and stay asleep" caught the eyes (and ears!) of consumers with, well, a rooster.
SILENCE YOUR ROOSTER
Saatchi & Saatchi Consumer Health + Wellness
BRAND Ambien CR CLIENT Sanofi-Aventis FROM LEFT: Andrew Curtis, copywriter; Jay Marrotte, art director
Ambien CR, the sleep medication that "helps you fall asleep fast and stay asleep" caught the eyes (and ears!) of consumers with, well, a rooster.
"The need for something that was symbolic came from the client," says Sergio Flores, associate creative director of Saatchi & Saatchi Healthcare. "We thought it would be interesting to take something that represents morning—a rooster—and have it come in the middle of the night."
DTC Ranking: Here's the year's most memorable advertising (Score based on recall 24 hours after viewing; 120=very strong)
A rooster (specially trained to stay up at night) assaults viewers with a series of antics—playing basketball, beating on drums, vacuuming—that gets consumers' attention by making them laugh. The 15-second spots, which mirror the myriad annoyances that keep people from falling or staying asleep, strike a personal chord: Whether it's worrying about a job, paying bills, etc., everyone has their own "rooster."
The spot teases consumers to visit Ambien CR's microsite, SilenceYourRooster.com. "We wanted to do it absurd, and blind enough so there'd be a better chance of getting people to go online," says Andrew Curtis, copywriter. "We wanted to create enough buzz and word of mouth to drive people to the branded microsite." In its first two weeks, the site received more than a million hits.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.